Abiocis Bio-Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 78.40%
- Profit Growth 40.89%
- Ebitda 475.22%
- Net Worth 90.23%
- Total Assets 48.24%
About Abiocis Bio-Science
Abiocis Bio-Science Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2018 (Six years and six months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Maity and Nimai Chand serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299TG2018PTC126179
-
Company No.
126179
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Abiocis Bio-Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nimai Chand
|
Director | 14-Aug-2018 | Current |
|
Prakash Maity
|
Director | 14-Aug-2018 | Current |
Financial Performance of Abiocis Bio-Science.
Abiocis Bio-Science Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 78.4% increase. The company also saw a substantial improvement in profitability, with a 40.89% increase in profit. The company's net worth Soared by an impressive increase of 90.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abiocis Bio-Science?
Unlock access to Abiocis Bio-Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vapiano Laboratories Private LimitedPrakash Maity is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abiocis Bio-Science?
Unlock and access historical data on people associated with Abiocis Bio-Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abiocis Bio-Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abiocis Bio-Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
